Search research articles
Contact Us
Filters
Showing results (11-20 of 150) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
Organ preservation in bladder carcinoma: a matter of selection
C J Logothetis
European Journal of Cancer & Clinical Oncology
|
September 1, 1987
Have aggressive chemotherapy regimens improved results in advanced germ cell tumors
C J Logothetis
The Urologic Clinics of North America
|
June 11, 1999
Serologic tumor markers, clinical biology, and therapy of prostatic carcinoma
J Kim, C J Logothetis
Journal of the National Cancer Institute
|
July 22, 1998
Prospects for optimized clinical management of bladder cancer by application of phenotypic markers
R E Millikan, C J Logothetis
Journal of the National Cancer Institute
|
November 18, 1992
Dose intensity in germ cell tumors: lessons learned?
C J Logothetis, R J Amato
World Journal of Urology
|
January 1, 1997
New approaches in the treatment of metastatic transitional-cell cancer of the bladder
D A Corral, C J Logothetis
Cancer Treatment Reviews
|
March 1, 1984
Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979
C J Logothetis, M L Samuels
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1986
Prognostic factors in disseminated germ cell tumors
C J Logothetis, M L Samuels
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Germ-cell tumor survivors: the price for cure
K Fizazi, I Chen, C J Logothetis
The Journal of Urology
|
February 1, 1996
Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal
J Herrada, P Dieringer, C J Logothetis
Page
of 15
Search research articles
Search
Showing results (11-20 of 150) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
Organ preservation in bladder carcinoma: a matter of selection
C J Logothetis
European Journal of Cancer & Clinical Oncology
|
September 1, 1987
Have aggressive chemotherapy regimens improved results in advanced germ cell tumors
C J Logothetis
The Urologic Clinics of North America
|
June 11, 1999
Serologic tumor markers, clinical biology, and therapy of prostatic carcinoma
J Kim, C J Logothetis
Journal of the National Cancer Institute
|
July 22, 1998
Prospects for optimized clinical management of bladder cancer by application of phenotypic markers
R E Millikan, C J Logothetis
Journal of the National Cancer Institute
|
November 18, 1992
Dose intensity in germ cell tumors: lessons learned?
C J Logothetis, R J Amato
World Journal of Urology
|
January 1, 1997
New approaches in the treatment of metastatic transitional-cell cancer of the bladder
D A Corral, C J Logothetis
Cancer Treatment Reviews
|
March 1, 1984
Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979
C J Logothetis, M L Samuels
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1986
Prognostic factors in disseminated germ cell tumors
C J Logothetis, M L Samuels
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Germ-cell tumor survivors: the price for cure
K Fizazi, I Chen, C J Logothetis
The Journal of Urology
|
February 1, 1996
Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal
J Herrada, P Dieringer, C J Logothetis
Page
of 15